Jazz Pharmaceuticals JAZZ Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's finished goods?
- Jazz Pharmaceuticals (JAZZ) reported finished goods of $119.5M in Q1 2026.
- How has Jazz Pharmaceuticals's finished goods changed year-over-year?
- Jazz Pharmaceuticals's finished goods decreased by 14.1% year-over-year, from $139.04M to $119.5M.
- What is the long-term trend for Jazz Pharmaceuticals's finished goods?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's finished goods has grown at a 33.3% compound annual growth rate (CAGR), from $33.64M to $141.6M.